Holen Sie sich die Stockscreener-App
39.88
2.22%
-1.035
Schlusskurs vom Vortag:
$40.91
Offen:
$40.93
24-Stunden-Volumen:
18,249
Relative Volume:
0.08
Marktkapitalisierung:
$377.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.17M
KGV:
-3.9346
EPS:
-10.1344
Netto-Cashflow:
$-82.84M
1W Leistung:
+1.06%
1M Leistung:
-13.46%
6M Leistung:
+91.07%
1J Leistung:
-31.22%
1-Tages-Spanne:
$39.00
$41.55
1-Wochen-Bereich:
$36.01
$42.70
52-Wochen-Spanne:
$10.29
$76.79
Korro Bio Inc Stock (KRRO) Company Profile
Firmenname
Korro Bio Inc
Sektor
Branche
Telefon
617-468-1999
Adresse
60 FIRST STREET, CAMBRIDGE
Vergleichen Sie KRRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
40.16 | 384.18M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.18 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.68 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
827.86 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.35 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-16 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-01-10 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2024-08-14 | Eingeleitet | William Blair | Outperform |
| 2024-03-28 | Bestätigt | H.C. Wainwright | Buy |
| 2024-02-27 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-11-10 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-09-22 | Herabstufung | Goldman | Buy → Neutral |
| 2021-01-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
| 2020-07-14 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-10-28 | Eingeleitet | Cowen | Outperform |
| 2019-10-28 | Eingeleitet | Goldman | Buy |
| 2019-10-28 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Korro Bio Inc Aktie (KRRO) Neueste Nachrichten
Can Korro Bio Inc. stock double in next 5 yearsMarket Movers & AI Optimized Trading Strategy Guides - newser.com
What high frequency data says about Korro Bio Inc.Analyst Upgrade & Technical Pattern Based Signals - newser.com
Will Korro Bio Inc. stock recover faster than market2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com
Automated trading signals detected on Korro Bio Inc.Market Activity Report & Consistent Profit Trading Strategies - newser.com
Trend analysis for Korro Bio Inc. this weekJuly 2025 Selloffs & Smart Investment Allocation Insights - newser.com
Why Korro Bio Inc. stock is favored by pension fundsPortfolio Risk Summary & Long-Term Safe Investment Plans - newser.com
Korro Bio’s KRRO-110 Study: A Potential Game-Changer in Genetic Therapy - MSN
Published on: 2025-11-01 04:19:56 - newser.com
Will Korro Bio Inc. stock deliver strong dividend growthWeekly Stock Analysis & Weekly Setup with High ROI Potential - newser.com
Why retail investors pile into Korro Bio Inc. stockJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
How to track smart money flows in Korro Bio Inc.Weekly Trend Report & Smart Money Movement Alerts - newser.com
Risk vs reward if holding onto Korro Bio Inc.Market Activity Report & High Accuracy Buy Signal Tips - newser.com
Clear Street Initiates Coverage of Korro Bio (KRRO) with Buy Recommendation - Nasdaq
This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
What makes Korro Bio Inc. stock attractive to growth fundsJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com
Key resistance and support levels for Korro Bio Inc.July 2025 PostEarnings & Detailed Earnings Play Strategies - newser.com
Custom strategy builders for tracking Korro Bio Inc.July 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Will Korro Bio Inc. stock attract more institutional investorsJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Clear Street initiates Korro Bio stock with Buy rating, $93 price target - Investing.com Canada
Clear Street initiates Korro Bio stock with Buy rating, $93 price target By Investing.com - Investing.com South Africa
What analysts say about Korro Bio Inc stockInflation Impact on Stocks & Free Rapid Return Acceleration - earlytimes.in
Is Korro Bio Inc. stock positioned for long term growthQuarterly Market Review & Low Volatility Stock Recommendations - newser.com
Finanzdaten der Korro Bio Inc-Aktie (KRRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Korro Bio Inc-Aktie (KRRO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Agarwal Vineet | Chief Financial Officer |
Nov 11 '24 |
Sale |
70.00 |
800 |
56,000 |
0 |
0.21%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):